Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.

Coffeng LE, Stolk WA, Zouré HG, Veerman JL, Agblewonu KB, Murdoch ME, Noma M, Fobi G, Richardus JH, Bundy DA, Habbema D, de Vlas SJ, Amazigo UV.

PLoS Negl Trop Dis. 2013;7(1):e2032. doi: 10.1371/journal.pntd.0002032. Epub 2013 Jan 31.


Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.

Kim YE, Sicuri E, Tediosi F.

PLoS Negl Trop Dis. 2015 Sep 11;9(9):e0004056. doi: 10.1371/journal.pntd.0004056. eCollection 2015.


African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.

Krotneva SP, Coffeng LE, Noma M, Zouré HG, Bakoné L, Amazigo UV, de Vlas SJ, Stolk WA.

PLoS Negl Trop Dis. 2015 Sep 24;9(9):e0004051. doi: 10.1371/journal.pntd.0004051. eCollection 2015.


Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.

Tekle AH, Zouré HG, Noma M, Boussinesq M, Coffeng LE, Stolk WA, Remme JH.

Infect Dis Poverty. 2016 Jun 27;5(1):66. doi: 10.1186/s40249-016-0160-7.


The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.

Noma M, Zouré HG, Tekle AH, Enyong PA, Nwoke BE, Remme JH.

Parasit Vectors. 2014 Jul 22;7:325. doi: 10.1186/1756-3305-7-325.


Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.

Tekle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, Noma M, Cousens S, Abiose A, Remme JH.

Parasit Vectors. 2012 Feb 7;5:28. doi: 10.1186/1756-3305-5-28.


The World Bank.

Bangoura O.

Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:31-3. doi: 10.1179/136485908X337463.


Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.

Stolk WA, Walker M, Coffeng LE, Basáñez MG, de Vlas SJ.

Parasit Vectors. 2015 Oct 22;8:552. doi: 10.1186/s13071-015-1159-9.


Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.

Coffeng LE, Stolk WA, Hoerauf A, Habbema D, Bakker R, Hopkins AD, de Vlas SJ.

PLoS One. 2014 Dec 29;9(12):e115886. doi: 10.1371/journal.pone.0115886. eCollection 2014.


The African Programme for Onchocerciasis Control (APOC).

Amazigo U.

Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:19-22. doi: 10.1179/136485908X337436.


Economic evaluation of Mectizan distribution.

Waters HR, Rehwinkel JA, Burnham G.

Trop Med Int Health. 2004 Apr;9(4):A16-25. Review.


Control of onchocerciasis.

Boatin BA, Richards FO Jr.

Adv Parasitol. 2006;61:349-94. Review.


Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.

Turner HC, Walker M, Churcher TS, Osei-Atweneboana MY, Biritwum NK, Hopkins A, Prichard RK, Basáñez MG.

Clin Infect Dis. 2014 Oct;59(7):923-32. doi: 10.1093/cid/ciu467. Epub 2014 Jun 18.


The Mectizan Donation Program (MDP).

Thylefors B.

Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:39-44. doi: 10.1179/136485908X337481.


Can ivermectin mass treatments eliminate onchocerciasis in Africa?

Winnen M, Plaisier AP, Alley ES, Nagelkerke NJ, van Oortmarssen G, Boatin BA, Habbema JD.

Bull World Health Organ. 2002;80(5):384-91.


Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa.

Plaisier AP, Alley ES, van Oortmarssen GJ, Boatin BA, Habbema JD.

Bull World Health Organ. 1997;75(3):237-45.


Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.

Alley WS, van Oortmarssen GJ, Boatin BA, Nagelkerke NJ, Plaisier AP, Remme JH, Lazdins J, Borsboom GJ, Habbema JD.

BMC Public Health. 2001;1:12. Epub 2001 Nov 6.


Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.

Turner HC, Walker M, Churcher TS, Basáñez MG.

Parasit Vectors. 2014 May 26;7:241. doi: 10.1186/1756-3305-7-241.

Supplemental Content

Support Center